SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-19-135032
Filing Date
2019-05-02
Accepted
2019-05-02 16:16:05
Documents
5
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d740512d10qa.htm 10-Q/A 27533
2 EX-10.1 d740512dex101.htm EX-10.1 685580
3 EX-31.1 d740512dex311.htm EX-31.1 10764
4 EX-31.2 d740512dex312.htm EX-31.2 10768
5 EX-32.1 d740512dex321.htm EX-32.1 4045
  Complete submission text file 0001193125-19-135032.txt   739721
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37766 | Film No.: 19792091
SIC: 2835 In Vitro & In Vivo Diagnostic Substances